Mariani et al identified histologic findings associated with lymph node metastases in patients with endometrial carcinoma. This can help identify patients who may benefit from lymph node sampling to determine therapy and prognosis. The authors are from the Mayo Clinic.
Parameters:
(1) histologic type of cancer
(2) p53 staining
(3) bcl-2 staining
Parameter |
Finding |
Points |
histologic type of cancer |
endometrioid |
0 |
|
non-endometrioid |
1 |
p53 staining |
< 33% |
0 |
|
>= 33% |
1 |
bcl-2 staining |
1+, 2+, 3+ |
0 |
|
completely negative |
1 |
number of risk factors associated with nodal metastasis =
= SUM(points for all 3 parameters)
Interpretation:
• minimum score: 0
• maximum score: 3
• The higher the score the greater the risk of lymph node metastasis.
Total Score |
Risk of Metastasis to Lymph Nodes |
0 |
6% |
1 |
13-17% |
2 |
28 - 34% |
3 |
55% |
Specialty: Hematology Oncology, Surgery, general, Obstetrics & Gynecology
ICD-10: ,